24 / 43
EXTREME: SG entre largos supervivientes que reciben
CTX de mantenimiento
*>2 years
Vermorken JB, et al. Poster presented at ASCO 2014 (Abstract No. 6021)
•
Median duration of maintenance treatment for cetuximab was 30.1 (7–271) weeks
•
RDI of cetuximab was ≥90% for 87% of these patients
7,4
31,7
10,1
33,7
0
10
20
30
40
50
ITT
Long-term survivors*
CT
Cetuximab + CT
Median OS (months)
p=0.04
n=25
n=31
n=222
n=220